Screener
PTC Therapeutics PTCT Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001070081-26-000012
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Selling, general and administrative | 86,183 | 80,961 |
| Change in the fair value of contingent consideration | — | (800) |
| Tangible asset impairment and losses on transactions, net | 927 | 77 |
| Total operating expenses | 227,592 | 205,871 |
| Income from operations | 44,959 | 970,225 |
| Interest expense, net | (49,030) | (34,092) |
| Other income (expense), net | 1,609 | (6,305) |
| (Loss) income before income tax expense | (2,462) | 929,828 |
Item 1. Financial Statements (unaudited)
FAQ
- What is PTC Therapeutics's total operating expenses?
- PTC Therapeutics (PTCT) reported total operating expenses of $227.59M in Q1 2026.
- How has PTC Therapeutics's total operating expenses changed year-over-year?
- PTC Therapeutics's total operating expenses increased by 10.6% year-over-year, from $205.87M to $227.59M.
- What is the long-term trend for PTC Therapeutics's total operating expenses?
- Over 4 years (2021 to 2025), PTC Therapeutics's total operating expenses has grown at a -1.4% compound annual growth rate (CAGR), from $913.04M to $863.72M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.
Ask your AI about PTC Therapeutics's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude